Johnson & Johnson (JNJ) 107.88 $JNJ
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 5:20PM CDT
Novo Nordisk (NVO) announced data from new analyses of the phase IIIa DUAL I and DUAL II studies on Xultophy.
Final Glance: Pharmaceuticals companies
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 4:45PM CDT
GlaxoSmithKline (GSK) announced that it has been found guilty of bribing non-government personnel by the Changsha Intermediate People's Court in Hunan Province, China.
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 3:45PM CDT
Novartis (NVS) announced that positive data on its pipeline candidate, LBH589 (panobinostat), was published in The Lancet Oncology.
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 2:59PM CDT
Flexion announced that the FDA has placed a clinical hold on patient enrollment and dosing in an ongoing phase IIb study on FX006.
Surprising Silver Lining for Gilead Sciences, inc. Stock
Brian Orelli, The Motley Fool - Motley Fool - Mon Sep 22, 2:37PM CDT
Shares of Gilead Sciences got knocked down last week after CVS Health released data showing higher discontinuation rates for hepatitis C patients taking Sovaldi than Gilead Sciences saw in its clinical trials. Source: Gilead Sciences ...
Is the Stock Market Ready to Plunge? Here Are 3 Things to Do Right Now
Sean Williams, The Motley Fool - Motley Fool - Mon Sep 22, 1:16PM CDT
Source: Flickr user Rafael Matsunaga. To say the stock market has had a good run since hitting its lows in March 2009 would be quite an understatement. Industries across the board have seen strength at one time or another, with select companies...
Midday Glance: Pharmaceuticals companies
AP - Mon Sep 22, 1:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Sep 22, 1:13PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Sep 22, 10:05AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon Sep 22, 10:05AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Twenty Employers to Attend Annual Life Science Hiring Event Next Week
PR Newswire - Mon Sep 22, 8:00AM CDT
HireLifeScience.com, the premier career networking website for the Life Science industries, will host its 5th annual career fair at The NJ Convention and Exposition Center at Raritan Center in Edison, NJ next week on Tuesday, September 30, 2014. The annual hiring event is sponsored by Novo Nordisk. Additional event sponsors include Covance and top generic drug company, Actavis, Inc. Additional companies who will be exhibiting and looking for new hires are Novartis, Johnson & Johnson, LifeCell, Cubist Pharmaceuticals, Regeneron, Daiichi Sankyo, Musculoskeletal Transplant Foundation (MTF), Acorda Therapeutics, Indegene, GE Healthcare, Amneal Pharmaceuticals, ACT Oncology, Sollers, Catalent Pharma Solutions, Ortho Clinical Diagnostics, MAQUET and Medidata Solutions.
Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning
GlobeNewswire - Mon Sep 22, 7:07AM CDT
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation, today announced it has appointed Scott Garrett as Vice President, Commercial Planning, a newly created position.
United States General Surgery Market Outlook to 2020
M2 - Mon Sep 22, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7dwb5q/united_states) has announced the addition of the "United States General Surgery Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). The report provides value, in millions of US dollars, and volume (in units) within market categories: - Bronchoscopes - Laryngoscopes - Ureteroscopes - Cystoscopes - Colonoscopes - Sigmoidoscopes - Esophagoscopes & Gastroscopes - Duodenoscopes - Laparoscopes - Hysteroscopes - Sinuscopes - Resectoscopes - Endoscopy Visualization Systems - Endoscopy Visualization System Components - Endoscopic Reprocessors - Endoscopy Fluid Management Systems - Capsule Endoscopy Systems - Surgical Generators - Bariatric Surgery Devices - Aesthetic Lasers and Energy Devices - Biopsy Devices - Hernia Repair - Non-Vascular Stents - Gynecological Devices Companies Mentioned - Olympus Corporation - Covidien plc - Intuitive Surgical, Inc. - C. R. Bard, Inc. - Ethicon Endo-Surgery, Inc. - KARL STORZ GmbH & Co. KG - Hologic, Inc. - PENTAX Medical Company - CareFusion Corporation - Johnson & Johnson - Cook Group Incorporated - Conceptus, Inc. - Devicor Medical Products, Inc. - Boston Scientific Corporation - Fujifilm Holdings Corporation - Given Imaging Ltd. - B. Braun Melsungen AG - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/7d...ted_states
Global In-Vitro Diagnostics (POC/Rapid Diagnostics) Market 2014-2020
M2 - Mon Sep 22, 3:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kjf5z9/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020" report to their offering. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue isolated from human body. IVD is classified into 3 types namely: clinical laboratory testing, near-patient testing, self-testing. IVD market is segmented by-techniques (including immunoassays, point of care, molecular diagnostics, hematology, coagulation, microbiology, clinical techniques, microbiology), product-type (including instruments, reagents, services, data management systems), usability (including disposable, reusable), applications (including diabetes, oncology, cardiology, HIV/AIDS, autoimmune disease, nephrology, drug testing), -end-user (including hospitals, laboratories, academics) and geography (globally). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Global Ivd Market, By Technique 5. Global Ivd Market, By Products 6. Global Ivd Market, By Application 7. Global Ivd Market, By End-Users 8. Regional Market Analysis 9. Company Developments 10. Major Player Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/kjf5z9/in_vitro
Mr. David Guerette Joins Matamec's Board of Directors
Marketwire - Fri Sep 19, 2:01PM CDT
Matamec Explorations Inc. ("Matamec" or the "Company"
(TSX VENTURE: MAT)(OTCQX: MHREF) is pleased to announce that Mr. David Guerette has joined the Board of Directors at the Annual Meeting of the Shareholders of the Company held on last June 19.
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 5:20PM CDT
Novo Nordisk (NVO) announced data from new analyses of the phase IIIa DUAL I and DUAL II studies on Xultophy.
Final Glance: Pharmaceuticals companies
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Sep 22, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 4:45PM CDT
GlaxoSmithKline (GSK) announced that it has been found guilty of bribing non-government personnel by the Changsha Intermediate People's Court in Hunan Province, China.
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 3:45PM CDT
Novartis (NVS) announced that positive data on its pipeline candidate, LBH589 (panobinostat), was published in The Lancet Oncology.
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 2:59PM CDT
Flexion announced that the FDA has placed a clinical hold on patient enrollment and dosing in an ongoing phase IIb study on FX006.
Surprising Silver Lining for Gilead Sciences, inc. Stock
Brian Orelli, The Motley Fool - Motley Fool - Mon Sep 22, 2:37PM CDT
Shares of Gilead Sciences got knocked down last week after CVS Health released data showing higher discontinuation rates for hepatitis C patients taking Sovaldi than Gilead Sciences saw in its clinical trials. Source: Gilead Sciences ...
Is the Stock Market Ready to Plunge? Here Are 3 Things to Do Right Now
Sean Williams, The Motley Fool - Motley Fool - Mon Sep 22, 1:16PM CDT
Source: Flickr user Rafael Matsunaga. To say the stock market has had a good run since hitting its lows in March 2009 would be quite an understatement. Industries across the board have seen strength at one time or another, with select companies...
Midday Glance: Pharmaceuticals companies
AP - Mon Sep 22, 1:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Sep 22, 1:13PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Sep 22, 10:05AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon Sep 22, 10:05AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Twenty Employers to Attend Annual Life Science Hiring Event Next Week
PR Newswire - Mon Sep 22, 8:00AM CDT
HireLifeScience.com, the premier career networking website for the Life Science industries, will host its 5th annual career fair at The NJ Convention and Exposition Center at Raritan Center in Edison, NJ next week on Tuesday, September 30, 2014. The annual hiring event is sponsored by Novo Nordisk. Additional event sponsors include Covance and top generic drug company, Actavis, Inc. Additional companies who will be exhibiting and looking for new hires are Novartis, Johnson & Johnson, LifeCell, Cubist Pharmaceuticals, Regeneron, Daiichi Sankyo, Musculoskeletal Transplant Foundation (MTF), Acorda Therapeutics, Indegene, GE Healthcare, Amneal Pharmaceuticals, ACT Oncology, Sollers, Catalent Pharma Solutions, Ortho Clinical Diagnostics, MAQUET and Medidata Solutions.
Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning
GlobeNewswire - Mon Sep 22, 7:07AM CDT
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation, today announced it has appointed Scott Garrett as Vice President, Commercial Planning, a newly created position.
United States General Surgery Market Outlook to 2020
M2 - Mon Sep 22, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7dwb5q/united_states) has announced the addition of the "United States General Surgery Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). The report provides value, in millions of US dollars, and volume (in units) within market categories: - Bronchoscopes - Laryngoscopes - Ureteroscopes - Cystoscopes - Colonoscopes - Sigmoidoscopes - Esophagoscopes & Gastroscopes - Duodenoscopes - Laparoscopes - Hysteroscopes - Sinuscopes - Resectoscopes - Endoscopy Visualization Systems - Endoscopy Visualization System Components - Endoscopic Reprocessors - Endoscopy Fluid Management Systems - Capsule Endoscopy Systems - Surgical Generators - Bariatric Surgery Devices - Aesthetic Lasers and Energy Devices - Biopsy Devices - Hernia Repair - Non-Vascular Stents - Gynecological Devices Companies Mentioned - Olympus Corporation - Covidien plc - Intuitive Surgical, Inc. - C. R. Bard, Inc. - Ethicon Endo-Surgery, Inc. - KARL STORZ GmbH & Co. KG - Hologic, Inc. - PENTAX Medical Company - CareFusion Corporation - Johnson & Johnson - Cook Group Incorporated - Conceptus, Inc. - Devicor Medical Products, Inc. - Boston Scientific Corporation - Fujifilm Holdings Corporation - Given Imaging Ltd. - B. Braun Melsungen AG - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/7d...ted_states
Global In-Vitro Diagnostics (POC/Rapid Diagnostics) Market 2014-2020
M2 - Mon Sep 22, 3:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kjf5z9/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020" report to their offering. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue isolated from human body. IVD is classified into 3 types namely: clinical laboratory testing, near-patient testing, self-testing. IVD market is segmented by-techniques (including immunoassays, point of care, molecular diagnostics, hematology, coagulation, microbiology, clinical techniques, microbiology), product-type (including instruments, reagents, services, data management systems), usability (including disposable, reusable), applications (including diabetes, oncology, cardiology, HIV/AIDS, autoimmune disease, nephrology, drug testing), -end-user (including hospitals, laboratories, academics) and geography (globally). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Global Ivd Market, By Technique 5. Global Ivd Market, By Products 6. Global Ivd Market, By Application 7. Global Ivd Market, By End-Users 8. Regional Market Analysis 9. Company Developments 10. Major Player Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/kjf5z9/in_vitro
Mr. David Guerette Joins Matamec's Board of Directors
Marketwire - Fri Sep 19, 2:01PM CDT
Matamec Explorations Inc. ("Matamec" or the "Company"
(TSX VENTURE: MAT)(OTCQX: MHREF) is pleased to announce that Mr. David Guerette has joined the Board of Directors at the Annual Meeting of the Shareholders of the Company held on last June 19. 
